Terms: = Pancreatic cancer AND HLF, Q16534, 3131, ENSG00000108924
6 results:
1. Intracellularly delivered human lactoferrin functions as an activator of Na
Kurimoto D; Hue Anh TD; Kasama R; Sato A
Biochem Biophys Res Commun; 2024 Feb; 695():149480. PubMed ID: 38215552
[TBL] [Abstract] [Full Text] [Related]
2. Comparison of 19G FNA Versus 22G FNB Needles for Endoscopic Ultrasound-Guided Fine-Needle Sampling of Subepithelial Tumors: Is Bigger Better?
Li J; Feng J; Gao S; Wang W; Huang L; Yi S; Xu H; Ding XW
J Ultrasound Med; 2024 Apr; 43(4):761-770. PubMed ID: 38167820
[TBL] [Abstract] [Full Text] [Related]
3. Nature and Nurture: What Determines Tumor Metabolic Phenotypes?
Mayers JR; Vander Heiden MG
Cancer Res; 2017 Jun; 77(12):3131-3134. PubMed ID: 28584183
[TBL] [Abstract] [Full Text] [Related]
4. SRPX2 promotes cell migration and invasion via FAK dependent pathway in pancreatic cancer.
Gao Z; Zhang J; Bi M; Han X; Han Z; Wang H; Ou Y
Int J Clin Exp Pathol; 2015; 8(5):4791-8. PubMed ID: 26191169
[TBL] [Abstract] [Full Text] [Related]
5. Suppression of Lefty expression in induced pluripotent cancer cells.
Saito A; Ochiai H; Okada S; Miyata N; Azuma T
FASEB J; 2013 Jun; 27(6):2165-74. PubMed ID: 23407711
[TBL] [Abstract] [Full Text] [Related]
6. [Antitumor effect of human lactoferrin against newly established human pancreatic cancer cell line SPA].
Sakamoto N
Gan To Kagaku Ryoho; 1998 Aug; 25(10):1557-63. PubMed ID: 9725049
[TBL] [Abstract] [Full Text] [Related]
